Literature DB >> 9448000

POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element.

V Budhram-Mahadeo1, M Parker, D S Latchman.   

Abstract

The estrogen receptor (ER) modulates transcription by forming complexes with other proteins and then binding to the estrogen response element (ERE). We have identified a novel interaction of this receptor with the POU transcription factors Brn-3a and Brn-3b which was independent of ligand binding. By pull-down assays and the yeast two-hybrid system, the POU domain of Brn-3a and Brn-3b was shown to interact with the DNA-binding domain of the ER. Brn-3-ER interactions also affect transcriptional activity of an ERE-containing promoter, such that in estradiol-stimulated cells, Brn-3b strongly activated the promoter via the ERE, while Brn-3a had a mild inhibitory effect. The POU domain of Brn-3b which interacts with the ER was sufficient to confer this activation potential, and the change of a single amino acid in the first helix of the POU homeodomain of Brn-3a to its equivalent in Brn-3b can change the mild repressive effect of Brn-3a to a stimulatory Brn-3b-like effect. These observations and their implications for transcriptional regulation by the ER are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448000      PMCID: PMC108815          DOI: 10.1128/MCB.18.2.1029

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

1.  Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain.

Authors:  J M Holloway; D P Szeto; K M Scully; C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

2.  Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor.

Authors:  N D Lakin; P J Morris; T Theil; T N Sato; T Möröy; M C Wilson; D S Latchman
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

3.  Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding.

Authors:  T Theil; B Rödel; F Spiegelhalter; T Möröy
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

4.  Multiple isoforms of the oestrogen receptor in endometrial cancer.

Authors:  S Marsigliante; A Muscella; V Ciardo; J R Puddefoot; G Leo; G P Vinson; C Storelli
Journal:  J Mol Endocrinol       Date:  1995-06       Impact factor: 5.098

5.  Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo.

Authors:  H Wang; G A Peters; X Zeng; M Tang; W Ip; S A Khan
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

6.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

Authors:  P Webb; G N Lopez; R M Uht; P J Kushner
Journal:  Mol Endocrinol       Date:  1995-04

7.  Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors.

Authors:  B A Ince; D J Schodin; D J Shapiro; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

8.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

9.  Estrogen receptor variants in normal human mammary tissue.

Authors:  E R Leygue; P H Watson; L C Murphy
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

10.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Authors:  V Cavaillès; S Dauvois; F L'Horset; G Lopez; S Hoare; P J Kushner; M G Parker
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  13 in total

1.  Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.

Authors:  Rieko Fujita; Samir Ounzain; Alice Chun Yin Wang; Richard John Heads; Vishwanie Shanie Budhram-Mahadeo
Journal:  Cell Stress Chaperones       Date:  2011-01-29       Impact factor: 3.667

Review 2.  Role of homeobox genes in normal mammary gland development and breast tumorigenesis.

Authors:  Hexin Chen; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

Authors:  D Chen; P E Pace; R C Coombes; S Ali
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Developmental effects of ectopic expression of the glucocorticoid receptor DNA binding domain are alleviated by an amino acid substitution that interferes with homeodomain binding.

Authors:  J M Wang; G G Préfontaine; M E Lemieux; L Pope; M A Akimenko; R J Haché
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  Multifunctional role of the Pitx2 homeodomain protein C-terminal tail.

Authors:  B A Amendt; L B Sutherland; A F Russo
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke.

Authors:  N J Alkayed; S Goto; N Sugo; H D Joh; J Klaus; B J Crain; O Bernard; R J Traystman; P D Hurn
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

8.  A simple technique for the prediction of interacting proteins reveals a direct Brn-3a-androgen receptor interaction.

Authors:  Daniel C Berwick; James K J Diss; Vishwanie S Budhram-Mahadeo; David S Latchman
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

9.  Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway.

Authors:  Samir Ounzain; Samantha Bowen; Chandrakant Patel; Rieko Fujita; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Breast Cancer Res       Date:  2011-01-17       Impact factor: 6.466

10.  Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.

Authors:  Vishwanie S Budhram-Mahadeo; Samantha Bowen; Sonia Lee; Christina Perez-Sanchez; Elizabeth Ensor; Peter J Morris; David S Latchman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.